 | | | | - Among its peer group, in spite of high Volatility, Increasing Rate is low | | - Most related stocks have also increased. Distribution industry +0.19% | | - Target price KRW 25,000, has 153% disparate to increase compared with stock price. | | - Institutions and Foreigners sell, Individuals buy | | - Turnover Rate and Price Range both proper | | - The main shareholding group is Individuals |
|
|
On Oct. 24, CTC BIO (060590) increased 1.75% to 9,860 won (US$8.70). It had declined 12.36% through the past month. Standard deviation, which indicates variableness, records 2% over the same period of time over one month.
Compared with its close competitors within the same industry, KOSDAQ, since the monthly volatility of CTC BIO was at a low level, the earnings rate over one month was also relatively lower than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -6.1%. By tumbling of stock price, return-on-risk is the lowest among its peer group in spite of low volatility. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -6.0, and thus the industrial comparison performance was not so good.
| Close Competitors | Earning rate (%) | STD (1Mo) | Return on
Risk (1Mo) | | 1 Mo | 3 Mo | 6 Mo | | A-motion(031860) | 13.9% | 8.2% | 2.4% | 4.3% | 3.2 | | IE(023430) | -20.1% | 20.1% | 108.8% | 4.0% | -5.0 | | MPK(065150) | 5.8% | -8.2% | -12.8% | 2.1% | 2.7 | | CTC BIO(060590) | -12.4% | -33.8% | -37.6% | 2.0% | -6.1 | | SAMT(031330) | -3.3% | 5.0% | -11.1% | 1.9% | -1.7 | | | | Distribution | -5.6% | -6.7% | -8.8% | 0.8% | -7.0 | | KOSDAQ | -4.8% | -6.3% | -7.5% | 0.9% | -6.0 |
|
CTC BIO(060590): 2Q(Apr ~ June) of 2016 Earnings (reported at Aug. 17. 2016)
| | Revenue | Operating Income | Net Income | | 2Q of 2016 | 296.6 T | -5.5 T | -0.7 T | | Previous Quarter | 5.6% increase | turn to a loss | turn to a loss | | YoY | 5.3% increase | turn to a loss | turn to a loss |
|
Financial structure Overview
| Compared with 4 close competitors with similar market capitalization within its industry, CTC BIO's P/B ratio, a financial ratio of a company's book value, and its P/E ratio, a price-paid ratio of annual net income, are both at a relatively lower level. |
P/E ratio and P/B ratio
| Close Compatitors | ROE | PER | PBR | Basic Date | | CTC BIO(060590) | 0.7 | 265.9 | 1.8 | June 2016 | | IE(023430) | 0.0 | - | - | June 2016 | | A-motion(031860) | -29.8 | - | 4.3 | June 2016 | | SAMT(031330) | 24.8 | 6.1 | 1.5 | June 2016 | | MPK(065150) | 0.4 | 965.2 | 4.0 | June 2016 |
Institutions and Foreigners sell, Individuals buy
From Oct. 17, institutions have been continously selling CTC BIO during the past five trading days. As a shareholding sum by investor group for the past four weeks, foreigners have sold 16,731 shares and institutions have sold 199,129 shares with a selling trend. However, during the same period, individuals have bought 215,860 shares with an increasing position.
| Cumulated shareholdings per investor group (1Mo) | | Total shareholdings per investor group |  | |  |
| * Other Investor groups, included as "other corporations", are considered as "Individuals". |
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp. |
![[KH Explains] No more 'Michael' at Kakao Games](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=645&simg=/content/image/2024/04/28/20240428050183_0.jpg&u=20240428180321)
